Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125256312 | 12525631 | 2 | F | 20151119 | 20160702 | 20160705 | 20160708 | EXP | US-ASTRAZENECA-2016SE71788 | ASTRAZENECA | 468.00 | DY | F | Y | 9.00000 | KG | 20160709 | OT | US | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125256312 | 12525631 | 1 | PS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 0 | 150 | MG | INJECTION | ||||||||
| 125256312 | 12525631 | 2 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 0 | 150 | MG | INJECTION | ||||||||
| 125256312 | 12525631 | 3 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 0 | 150 | MG | INJECTION | ||||||||
| 125256312 | 12525631 | 4 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 0 | 150 | MG | INJECTION | ||||||||
| 125256312 | 12525631 | 5 | SS | VIANI MITE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | U | 0 | 1 | MG | INHALATION VAPOUR, LIQUID | |||||||
| 125256312 | 12525631 | 6 | SS | RECTODELT | PREDNISONE | 1 | Unknown | U | 0 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125256312 | 12525631 | 1 | Antiviral prophylaxis |
| 125256312 | 12525631 | 2 | Antiviral prophylaxis |
| 125256312 | 12525631 | 3 | Antiviral prophylaxis |
| 125256312 | 12525631 | 4 | Antiviral prophylaxis |
| 125256312 | 12525631 | 5 | Product used for unknown indication |
| 125256312 | 12525631 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125256312 | 12525631 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125256312 | 12525631 | Bronchiolitis | |
| 125256312 | 12525631 | Oxygen consumption increased | |
| 125256312 | 12525631 | Respiratory failure | |
| 125256312 | 12525631 | Respiratory syncytial virus infection | |
| 125256312 | 12525631 | Upper respiratory tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125256312 | 12525631 | 1 | 20151105 | 20151105 | 0 | |
| 125256312 | 12525631 | 2 | 20151207 | 20151207 | 0 | |
| 125256312 | 12525631 | 3 | 20160114 | 20160114 | 0 | |
| 125256312 | 12525631 | 4 | 20160211 | 20160211 | 0 | |
| 125256312 | 12525631 | 5 | 20151219 | 20160106 | 0 | |
| 125256312 | 12525631 | 6 | 20151219 | 20151219 | 0 |